library.onepin.app/chonluten Peptide Education Library

Education only, not medical advice◆ 21+◆ Every dose is an example to finalize with a licensed provider

OnePin Peptide Library · Bioregulators

Bioregulators Khavinson bioregulator tetrapeptide Not FDA-approved · investigational

Chonluten

Chonluten (Khavinson)

Khavinson bioregulator tetrapeptideRespiratory/GI mucosal regulatorMucosal barrier gene modulator

Chonluten (Thr-Glu-Asp-Gly) is a Khavinson bioregulator tetrapeptide targeting respiratory and gastrointestinal mucosal tissue gene expression. It supports mucosal epithelial cell function, barrier integrity, and tissue maintenance in both the lungs and GI tract.

Quick Start

Route

SubQ injection

Start low

5 mg daily

Frequency

Daily for 10-20 day course

Timing

No fasting required

SubQ injection, any time of day. 10-20 day courses, 2-3 cycles per year with 4-6 months between courses (Khavinson protocol). Pin alone or with other bioregulators only.

❋

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first

Quick Start

Conservative start

5 mg daily · SubQ injection · Daily for 10-20 day course

Lowest starting point. Hold about a week to assess tolerance before stepping up.

5 mg daily

Daily for 10-20 day course

Standard

Pulmonary Optimization

10-20 mg · Oral · Daily

anecdotal · community

10-20 mg

Daily

Reconstitution CalculatorU-100

Vial strength

BAC water

Target dose

050100u

Draw to

— units

◆

How it works

Chonluten modulates gene expression in mucosal epithelial cells of the respiratory tract and GI system, supporting mucin production, tight junction protein expression, and mucosal immune defense pathways.

What to expect

Early

Days 1–7

Days 1-10: Gene changes initiated.

Mid

Weeks 2–4

Weeks 2-8: Mucosal gene programs established.

Later

Weeks 4–12

Months: Sustained mucosal support.

Evidence

HumanPresent

AnimalPresent

In-vitroPresent

2013Peptide bioregulators: the new class of geroprotectors. Communication 1. Results of experimental studies · Khavinson VK, Kuznik BI, Advances in Gerontology ↗review

2013Peptide bioregulators: the new class of geroprotectors. Message 2. Clinical studies results · Khavinson VK, Kuznik BI, Advances in Gerontology ↗review

2002Peptides and Ageing · Anisimov VN, Khavinson VK, Neuroendocrinology Letters ↗review

2000[Application of peptide bioregulators in gerontology: results and perspectives] · Khavinson VK, Advances in Gerontology ↗review

The honest take

◆

Dual respiratory/GI mucosal support

Bioregulatory mechanism targeting mucosal epithelium in both organ systems.

Interactions & stacking

What's safe to combine, and what belongs in a separate pin.

Safe & synergistic

BPC-157Chonluten targets GI/respiratory mucosal gene expression, BPC-157 drives mucosal tissue repair. Complementary. Pin separately.

VIPBoth support respiratory and GI mucosal function through different pathways. Pin separately.

Keep separate

ALL (syringe)PIN ALONE.

GHK-CuCopper degrades bioregulators.

Side effects & safety

Commonly reported

Very well tolerated

Less common & notes

Excellent safety profile.

Pharmacokinetics

Illustrative plasma concentration · 24 h

Half-life

0.5h

Peak · Tmax

0.05h

Elimination

2.5h

Activity

~60 days (mucosal gene expression changes persist weeks to months after peptide clearance)

Storage. Standard BAC water 2-8C. 21-28 days.

Regulatory status

Not FDA-approved. Research peptide.

Put it to work

Calculate, log & track

Open Chonluten straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Chonluten in the app →

Go deeper

The guide & community

The complete Chonluten walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗

Open in app Community